Global Blood Therapeutics Investor Relations Material
Latest events
Investor Conference 2022
Global Blood Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Global Blood Therapeutics Inc
Access all reports
Global Blood Therapeutics Inc. is a biopharmaceutical company focused on developing and delivering treatments for blood disorders. The company is primarily known for its work in addressing sickle cell disease, offering innovative therapies aimed at improving the quality of life for patients suffering from this and other blood-related conditions. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
GBT
Country
🇺🇸 United States